The exploratory clinical development of tucaresol, an antisickling agent, using a novel surrogate marker
Files
Date
1995
Authors
Rolan, Paul Edward
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Thesis
Citation
Statement of Responsibility
Conference Name
Abstract
School/Discipline
Dept. of Clinical and Experimental Pharmacology
Dissertation Note
Thesis (M.D.) -- University of Adelaide, Dept. of Clinical and Experimental Pharmacology, 1995
Provenance
Copyright material removed from digital thesis. See print copy in University of Adelaide Library for full text.
This electronic version is made publicly available by the University of Adelaide in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exception. If you are the author of this thesis and do not wish it to be made publicly available or If you are the owner of any included third party copyright material you wish to be removed from this electronic version, please complete the take down form located at: http://www.adelaide.edu.au/legals
This electronic version is made publicly available by the University of Adelaide in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exception. If you are the author of this thesis and do not wish it to be made publicly available or If you are the owner of any included third party copyright material you wish to be removed from this electronic version, please complete the take down form located at: http://www.adelaide.edu.au/legals
Description
Copies of author's previously published articles inserted
Describes the exploratory clinical development of tucaresol, consisting of three studies performed on humans and subsequent in vitro and animal studies investigating the possible effects on the immune system. Demonstrates that rational drug design may be an efficient way of selecting potential therapeutic candidates.
xxi, 265 leaves
Describes the exploratory clinical development of tucaresol, consisting of three studies performed on humans and subsequent in vitro and animal studies investigating the possible effects on the immune system. Demonstrates that rational drug design may be an efficient way of selecting potential therapeutic candidates.
xxi, 265 leaves